Houston (1)

Recruiting (1)

phase 1 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

capecitabine (1)

carboplatin (1)

docetaxel (1)

fluorouracil (1)

hafnium oxide-containing nanoparticles nbtxr3 (1)

intensity-modulated radiation therapy (1)

leucovorin (1)

oxaliplatin (1)

paclitaxel (1)

drug (1)

other (1)

radiation (1)

Other (1)

Interventional (1)

cervical esophagus adenocarcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Dec 31, 2022